Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSRI Response Prediction in Bipolar Depression via 5-HT1A PET
NCT02473250Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine, citalopram in bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Started Jan 2015; status: completed.
02
Drugs
fluoxetinecitalopram
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02473250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473250.